Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer

Gastric Cancer

Volumn 5, Issue 3, 2002, Pages 148-153

  Yasuda, Mitsuhiro ^a   Takesue, Fumio ^a   Inutsuka, Sadaaki ^a   Honda, Masayuki ^a   Nozoe, Tadahiro ^a   Korenaga, Daisuke ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Gastric cancer; Prognosis; Serum activity; Superoxide dismutase

Indexed keywords

SUPEROXIDE DISMUTASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GASTRECTOMY; HOST RESISTANCE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TUMOR GROWTH;

ADULT; AGE FACTORS; AGED; CARCINOMA; ENZYME TESTS; HUMANS; JAPAN; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH; STOMACH NEOPLASMS; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036035293     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101200200026     Document Type: Article

References (31)

1. Borek C. Radiation and chemically induced transformation: Free radicals, antioxidants and cancer. Br J Cancer 1987;55(Suppl VIII):74-86.
2. Sahu SC. Roles of oxygen free radicals in the molecular mechanisms of carcinogenesis: A review. J Environ Sci Health 1991;C9:83-112.
3. Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull 1993;49:523-44.
4. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 1996;313:17-29.
5. Öztürk HS, Karaayvaz M, Kaçmaz M, Kavutcu M, Akgül H, Durak I. Activities of the enzymes participating in purine and free-radical metabolism in cancerous human colorectal tissues. Cancer Biochem Biophys 1998;16:157-68.
6. Van Driel BEM, Lyon H, Hoogenraad DCJ, Anten S, Hansen U, Van Noorden CIF. Expression of CuZn- and Mn-superoxide dismutase in human colorectal neoplasms. Free Radical Biol Med 1997;23:435-44.
7. Kurokawa H, Sakimoto M, Yamashita Y, Murata T, Kajiyama M. Manganese superoxide dismutase (Mn-SOD) correlates with prognosis of patients with oral squamous cell carcinoma. Fukuoka Acta Med 1998;89:22321-7.
8. Durak I, Bedük Y, Kavutcu M, Öztürk S, Canbolat O, Ulutepe S. Activities of superoxide dismutase and glutathione peroxidase enzymes in cancerous and non-cancerous human kidney tissues. Int Urol Nephrol 1997;29:5-11.
9. Ahmed MI, Fayed ST, Hossein H, Tash FM. Lipid peroxidation and antioxidant status in human cervical carcinoma. Dis Markers 1999;15:283-91.
10. Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol 1997;92:2260-3.
11. Janssen AML, Bosman CB, Sier CFM, Griffioen G, Kubben FJGM, Lamers CBHW, et al. Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br J Cancer 1998;78:1051-7.
12. Janssen AML, Bosman CB, Kruidenier L, Griffioen G, Lamers CBHW, van Krieken JHJM, et al. Superoxide dismutases in the human colorectal cancer sequence. J Cancer Res Clin Oncol 1999;125:327-35.
13. Izutani R, Asano S, Imano M, Kuroda D, Kato M, Ohyanagi H. Expression of manganese superoxide dismutase in esophageal and gastric cancers. J Gastroenterol 1998;33:816-22.
14. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. Gastric Cancer 1998;1:10-24.
15. Maehara Y, Oshiro T, Oiwa H, Oda S, Baba H, Akazawa K, Sugimachi K. Gastric carcinoma in patients over 70 years of age. Br J Surg 1995;82:102-5.
16. Bittner R, Schirrow H, Burrers M, Roscher R, Krautzberger W, Oettinger W, et al. Total gastrectomy. A 15-year experience; reference to the patient over 70 years of age. Arch Surg 1985;120:1120-5.
17. Abdel-Aziz AF, El-Naggar MM. Superoxide dismutase activities in serum and white blood cells of patients with some malignancies. Cancer Lett 1997;113:61-4.
18. Ishikawa M, Yaginuma Y, Hayashi H, Shimizu T, Endo Y, Taniguchi N. Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma. Cancer Res 1990;50:2538-42.
19. Schadendorf D, Zuberbier T, Diehl S, Schadendorf C, Czarnetzki BM. Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma. Melanoma Res 1995;5:351-3.
20. Canbolat O, Akyol Ö, Kavutcu M, Isik Ü, Durak I. Serum adenosine deaminase and total superoxide dismutase activities before and after surgical removal of cancerous laryngeal tissue. J Laryngol Otol 1994;108:849-51.
21. Durak I, Akyol Ö, Canbolat O, Buyukberber S, Sencan O. Mn- and CuZn-superoxide dismutase activities during acute myocardial infarction. Clin Chem 1993;39:911-12.
22. Marklund S. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta Physiol Scand Suppl 1980;492:19-23.
23. Nakata T, Suzuki K, Fujii J, Ishikawa M, Taniguchi N. Induction and release of manganous superoxide dismutase from mitochondria of human umbilical vein endothelial cells by tumor necrosis factor-α and interleukin-1α. Int J Cancer 1993;55:646-50.
24. Taniguchi N. Clinical significances of superoxide dismutases: Changes in aging, diabetes, ischemia, and cancer. Adv Clin Chem 1992;29:1-59.
25. Korenaga D, Takesue F, Kido K, Yasuda M, Inutsuka S, Honda M, Nagahama S. Impaired antioxidant defense system of colonic tissue and cancer development in dextran sulfate sodium-induced colitis in mice. J Surg Res 2002;102:144-9.
26. Petkau A. Role of superoxide dismutase in modification of radiation injury. Br J Cancer 1987;55(Suppl VIII):87-95.
27. Oberley LW. Free radical biology: A paradox in cancer research. J Natl Cancer Inst 1990;82:902-3.
28. Urano M, Kuroda M, Reynolds R, Oberley TD, St Clair DK. Expression of manganese superoxide dismutase reduces tumour control radiation dose: Gene-radiotherapy. Cancer Res 1995;55:2490-3.
29. Wong GH. Protective roles of cytokines against radiation: Induction of mitochondrial MnSOD. Biochem Biophys Acta 1995;1271:205-9.
30. Hirose K, Longo DL, Oppenheim JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumour cells exposed to interleukin-1, tumour necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 1993;7:361-8.
31. Zyad A, Benard J, Tursz T, Clarke R, Chouaib S. Resistance to TNF-α and adriamycin in the human breast cancer MCF-7 cell line: Relationship to MDR, MnSOD, and TNF gene expression. Cancer Res 1994;54:825-31.